FDA approves new Actos bladder cancer warning

more+
less-

The Food and Drug Administration has approved a new warning about the link between the diabetes drug Actos and bladder cancer. The agency called for the new warning after a study found that patients who use Actos for at least one year are 40% more likely to develop bladder cancer.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Personal Injury Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hissey Kientz LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »